Clinical Trial Update: Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type [Phase 3]

View source ↗

Summary

A Phase 3 trial sponsored by Solvay Pharmaceuticals evaluating treatment for psychosis and behavioral disturbances in elderly patients with Alzheimer's-type dem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type | Phase 3 | Status: TERMINATED